| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Adma Biologics, Inc. (ADMA) has 9 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. ADMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.26M | $18.35M | - | |
| Dir | 2.05M | $16.61M | - | |
| Dir | 488.9K | $3.97M | - | |
| COO | 446.2K | $3.62M | - | |
| Dir | 263.0K | $2.14M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 3, 2016 | Lenz Brian | Chief Financial Officer | Buy | 2,500 | $6.50 | $16,250.00 | +41.7% | |
| May 3, 2016 | Grossman Adam S66 | President &CEO | Buy | 200,000 | $6.50 | $1,300,000.00 | +31.1% | |
| Dec 18, 2015 | Grossman Jerrold B68 | Director | Buy | 4,000 | $8.48 | $33,918.40 | +7.1% | |
| Dec 18, 2015 | Grossman Adam S66 | President &CEO | Buy | 6,400 | $8.47 | $54,224.00 | +1.0% | |
| Dec 8, 2015 | Grossman Adam S66 | President &CEO | Buy | 500 | $9.00 | $4,500.73 | - | |
| Dec 7, 2015 | Grossman Jerrold B68 | Director | Buy | 500 | $9.01 | $4,502.50 | +0.9% | |
| Dec 2, 2015 | Grossman Jerrold B68 | Director | Buy | 6,000 | $9.16 | $54,960.60 | +12.0% | |
| Dec 2, 2015 | Lenz Brian | Chief Financial Officer | Buy | 1,000 | $9.15 | $9,150.78 | +6.3% | |
| Dec 2, 2015 | Grossman Adam S66 | President &CEO | Buy | 2,250 | $9.15 | $20,583.83 | +0.1% | |
| Dec 1, 2015 | Grossman Adam S66 | President &CEO | Buy | 1,800 | $9.17 | $16,512.66 | +0.3% |